Israel Signs MoU With NRx Pharmaceuticals For Commercialization Of Local Covid-19 Vaccine
Israel has struck a partnership with the United States based pharma company NRx Pharmaceuticals for completion of trials and commercialization of the Covid-19 vaccine that has been developed in Israel called BriLife. A memorandum of understanding was signed between NRx and the Israel Institute for Biological Research on Monday, and the two parties said that…









